YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

宜 昌 東 陽 光 長 江 藥 業 股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 01558)

Supplemental Form of Proxy to the Revised Form of Proxy for the

2020 First Extraordinary General Meeting to be held on 22 January 2020

Number of Shares Related

domestic shares

to this Supplemental Form of Proxy

H shares

to the Revised Form of Proxy (Note 1)

I/We (Note 2)

of (address)

being the registered holder(s) of (Note 3)

domestic shares/H shares of RMB1.00

each in the share capital of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (the "Company") hereby appoint the Chairman of the meeting

or

(Note 4)

of (address)

as my/our proxy to attend and vote for me/us and on my/our behalf at the 2020 first extraordinary general meeting of the Company (the "2020 1st EGM") to be held at Conference Room, 4/F, Administration Building, Dongyangguang Scientific Park, No. 368 Zhen An Zhong Road, Chang'an County, Dongguan, Guangdong Province, the People's Republic of China (the "PRC") at 10:00 a.m. on Wednesday, 22 January 2020 (or at any adjournment thereof) in respect of the resolutions as set out in the revised notice of 2019 fourth extraordinary general meeting (the "2019 4th EGM") dated 16 December 2019 and the supplemental notice to the revised notice of 2019 4th EGM dated 3 January 2020 as hereunder indicated and, if no such indication is given, as my/our proxy thinks fit.

Special Resolution

For (Note 5)

Against (Note 5)

Abstain (Note 5)

2. To consider and approve the proposed transaction under the Supplemental Agreement dated 26 December 2019 entered into between the Company and Sunshine Lake Pharma.

Date:

Signature (Note 6):

Notes:

  1. Please insert the number of shares of the Company registered in your name(s) to which this supplemental form of proxy to the revised form of proxy ("this Supplemental Form of Proxy") relates. If a number is inserted, this Supplemental Form of Proxy will be deemed to relate only to those shares. If no number is inserted, this Supplemental Form of Proxy will be deemed to relate to all shares of the Company registered in your name(s) (whether alone or jointly with others).
  2. Please insert the full name(s) and address(es) as registered in the register of members of the Company in BLOCK LETTERS.
  3. Please insert the number of shares of the Company registered in your name(s) and delete as appropriate.
  4. If any proxy other than the Chairman of the meeting of the Company is preferred, please strike out the words "the Chairman of the meeting or" and insert the name of the proxy desired in the space provided. A shareholder may appoint one or more proxies to attend and vote on his/her behalf. A proxy need not be a shareholder of the Company. Any alteration made to this Supplemental Form of Proxy must be initialed by the person who signs it.
  5. Important: If you wish to vote for any resolution, please put a tick in the box marked "FOR" or insert the number of shares held by you. If you wish to vote against any resolution, please put a tick in the box marked "AGAINST" or insert the number of shares held by you. If you want to abstain from voting on any resolution, please put a tick in the box marked "ABSTAIN" or insert the number of shares held by you. If no direction is given, your proxy may vote as he/she thinks fit. The shares abstained will be counted in the calculation of the required majority.
  6. This Supplemental Form of Proxy must be signed by you or your attorney duly authorized in writing or, in the case of a corporation, must be either executed under its common seal or under the hand of its director or attorney or other officer duly authorized. In case of joint holders, this Supplemental Form of Proxy may be signed by any of such joint holders.
  7. To be valid, this Supplemental Form of Proxy and, if such proxy is signed by a person on behalf of the appointer pursuant to a power of attorney or other authority, a notarized copy of that power of attorney or other authority must be delivered, for holders of domestic shares, to the Company's board office at Securities Department, Dongyangguang Scientific Park, No. 368 Zhen An Zhong Road, Chang'an County, Dongguan, Guangdong Province, the PRC, or for holders of H shares, to the Company's H share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 24 hours before the time for holding of the 2020 1st EGM or any adjournment thereof (i.e. before 10:00 a.m. on Tuesday, 21 January 2020).
  8. Where there are joint holders of any share of the Company, any one of such persons may vote at the 2020 1st EGM, either personally or by proxy, in respect of such share as if he or she was solely entitled thereto, but if more than one of such joint holders are present at the 2020 1st EGM, personally or by proxy, that one of the said persons so present whose name stands first on the register in respect of such share shall alone be entitled to vote in respect thereof. The vote of the senior joint shareholder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint shareholder(s) and for this purpose, seniority will be determined by the order in which the names stand in the register of members of the Company in respect of the joint shareholding of such shares.
  9. This Supplemental Form of Proxy is for the purpose of the supplemental resolution set out in the supplemental notice to the revised notice of 2019 4th EGM dated 16 December 2019 (the "Supplemental Notice") and only serves as a supplement to the revised form of proxy for the 2020 1st EGM.
  10. This Supplemental Form of Proxy will not affect the validity of any form of proxy duly completed by you in respect of the resolution set out in the revised notice of 2019 4th EGM dated 16 December 2019. If you have validly appointed a proxy to attend and act for you at the 2020 1st EGM but do not complete and deliver this Supplemental Form of Proxy, your proxy will be entitled to vote at his/her discretion on the special resolution numbered 2 set out in the Supplemental Notice. If you do not duly complete and deliver the form of proxy despatched to the Shareholders on 13 November 2019 and/or the revised form of proxy but have duly completed and delivered this Supplemental Form of Proxy and validly appointed a proxy to attend and act for you at 2020 1st EGM, your proxy will be entitled to vote at his/her discretion on the special resolution set out in the Revised Notice of 2019 4th EGM dated 16 December 2019.
  11. Please be advised that completion and delivery of this Supplemental Form of Proxy will not preclude you from attending and voting at the 2020 1st EGM or any of its adjournments in person should you so wish.
  12. Unless otherwise defined, capitalized terms used in this Supplemental Form of Proxy shall have the same meaning as those defined in the announcements dated 13 November 2019, 12 December 2019 and 26 December 2019 of the Company.

Attachments

  • Original document
  • Permalink

Disclaimer

Yichang Hec Changjiang Pharmaceutical Co. Ltd. published this content on 02 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 January 2020 09:56:05 UTC